In the current issue:
-
Treatment of Castleman disease from the perspective of the year 2026
Adam Zdeněk et al. -
Ewing sarcoma – current diagnostic and therapeutic approaches
Nohejlová-Medková Anna et al. -
Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case
Maezawa Yosuke et al.
Reviews
Klin Onkol 2026; 39(2): 86-98.
DOI: 10.48095/ccko202686.
Keywords: Castleman disease – siltuximab – rituximab – anakinra – ruxolitinib – sirolimus – rapamycin – daratumab – bortezomib
Authors: Adam Zdeněk, Řehák Zdeněk, Boichuk Ivanna, Horváth Teodor, Adamová Zuzana, Štork Martin, Pour Luděk2026-04-15:Treatment of Castleman disease from the perspective of the year 2026
Keywords: Castleman disease – siltuximab – rituximab – anakinra – ruxolitinib – sirolimus – rapamycin – daratumab – bortezomib
Authors: Adam Zdeněk, Řehák Zdeněk, Boichuk Ivanna, Horváth Teodor, Adamová Zuzana, Štork Martin, Pour Luděk2026-04-15:Treatment of Castleman disease from the perspective of the year 2026
Klin Onkol 2026; 39(2): 99-104.
DOI: 10.48095/ccko202699.
Keywords: Ewing sarcoma – chemotherapy – targeted therapy
Authors: Nohejlová-Medková Anna, Pacas Pavel, Kopečková Kateřina2026-04-15:Ewing sarcoma – current diagnostic and therapeutic approaches
Keywords: Ewing sarcoma – chemotherapy – targeted therapy
Authors: Nohejlová-Medková Anna, Pacas Pavel, Kopečková Kateřina2026-04-15:Ewing sarcoma – current diagnostic and therapeutic approaches
Klin Onkol 2026; 39(2): 105-111.
DOI: 10.48095/ccko2026105.
Keywords: colorectal cancer – circulating tumor DNA – minimal residual disease – adjuvant chemotherapy – liquid biopsy – personalized oncology
Authors: Pirshtuk Alina, Büchler Tomáš, Vymetálková Veronika2026-04-15:Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer – a review of current evidence and perspectives
Keywords: colorectal cancer – circulating tumor DNA – minimal residual disease – adjuvant chemotherapy – liquid biopsy – personalized oncology
Authors: Pirshtuk Alina, Büchler Tomáš, Vymetálková Veronika2026-04-15:Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer – a review of current evidence and perspectives
Case report
Klin Onkol 2026; 39(2): 112-116.
DOI: 10.48095/ccko2026112.
Keywords: leiomyomatosis – adenomyosis – fumarate hydratase – intravascular propagation
Authors: Bartoš Vladimír, Hudec Boris, Baloghová Erika2026-04-15:Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene – a rare finding simulating malignancy
Keywords: leiomyomatosis – adenomyosis – fumarate hydratase – intravascular propagation
Authors: Bartoš Vladimír, Hudec Boris, Baloghová Erika2026-04-15:Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene – a rare finding simulating malignancy
Klin Onkol 2026; 39(2): 117-121.
DOI: 10.48095/ccko2026117.
Keywords: breast cancer – late recurrence – second recurrence
Authors: Maezawa Yosuke, Terada Takeshi, Kobayashi Hiroyuki, Ohara Gen, Saito Takeshi, Takayashiki Norio, Satoh Hiroaki2026-04-15:Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case
Keywords: breast cancer – late recurrence – second recurrence
Authors: Maezawa Yosuke, Terada Takeshi, Kobayashi Hiroyuki, Ohara Gen, Saito Takeshi, Takayashiki Norio, Satoh Hiroaki2026-04-15:Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case
Onkology in pictures
Klin Onkol 2026; 39(2): 122-124.
DOI: 10.48095/ccko2026122.
Authors: Řehák Zdeněk, Palácová Markéta, Soboličová Sandra, Fabián Pavel2026-04-15:FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
Authors: Řehák Zdeněk, Palácová Markéta, Soboličová Sandra, Fabián Pavel2026-04-15:FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
Letter to the Editor
Klin Onkol 2026; 39(2): 126.
Authors: Uchiyama Masahiro, Maezawa Yosuke, Satoh Hiroaki, Hasegawa Ryuichi 2026-04-15:Cancer patients admitted to intensive care unit
Authors: Uchiyama Masahiro, Maezawa Yosuke, Satoh Hiroaki, Hasegawa Ryuichi 2026-04-15:Cancer patients admitted to intensive care unit